AR045341A1 - ACILUREA COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS, USE OF THE COMPOUNDS IN THE PREPARATION OF MEDICINES, AND PROCESSES FOR THE PREPARATION OF THE COMPOUNDS - Google Patents

ACILUREA COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS, USE OF THE COMPOUNDS IN THE PREPARATION OF MEDICINES, AND PROCESSES FOR THE PREPARATION OF THE COMPOUNDS

Info

Publication number
AR045341A1
AR045341A1 ARP040102812A ARP040102812A AR045341A1 AR 045341 A1 AR045341 A1 AR 045341A1 AR P040102812 A ARP040102812 A AR P040102812A AR P040102812 A ARP040102812 A AR P040102812A AR 045341 A1 AR045341 A1 AR 045341A1
Authority
AR
Argentina
Prior art keywords
compounds
preparation
processes
pharmaceutical compositions
pyrrolidin
Prior art date
Application number
ARP040102812A
Other languages
Spanish (es)
Original Assignee
Telik Inc
Sanwa Kaguku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/060,967 external-priority patent/US6670364B2/en
Priority claimed from US10/637,746 external-priority patent/US6962926B2/en
Application filed by Telik Inc, Sanwa Kaguku Kenkyusho Co Ltd filed Critical Telik Inc
Publication of AR045341A1 publication Critical patent/AR045341A1/en

Links

Abstract

Compuestos de acilurea de fórmula A y de fórmula B y sus sales farmacéuticamente aceptables; en donde: m es 1, 2 o 3(excepto que cuando X es CH2, m es 1):; n es 4 o 5; p es 0 o 1; R1 es pirrolidin-1-ilo, piperidin-1-ilo, morfolin-4-ilo, piperazin-1-ilo, 4-metilpiperazin-1-ilo o hexahidroazepin-1-ilo; R2 es dimetilamino, etilmetilamino, dietilamino, pirrolidin-1-ilo o piperidín-1-ilo; y X es O, CH2, NH, o N(CH3). Los compuestos son antagonistas de la función MCP-1, y son útiles en la prevención y tratamiento de enfermedades autoinmunitarias e inflamatorias crónicas o agudas tales como ateroesclerosis, enfermedad de Crohn, nefropatía diabética, enfermedad intestinal inflamatoria, esclerosis múltiple, nefritis, pancreatitis, fibrosis pulmonar, soriasis, restenosis, artritis reumatoide y rechazo de trasplantes; y de enfermedades de hipersensibilidad alérgica tales como rinitis alérgica y asma. Además se describen composiciones farmacéuticas que comprenden los compuestos, el uso de estos compuestos en la elaboración de medicamentos, y procesos para la preparación de los compuestos.Acylurea compounds of formula A and formula B and their pharmaceutically acceptable salts; where: m is 1, 2 or 3 (except that when X is CH2, m is 1) :; n is 4 or 5; p is 0 or 1; R1 is pyrrolidin-1-yl, piperidin-1-yl, morpholin-4-yl, piperazin-1-yl, 4-methylpiperazin-1-yl or hexahydroazepin-1-yl; R2 is dimethylamino, ethylmethylamino, diethylamino, pyrrolidin-1-yl or piperidin-1-yl; and X is O, CH2, NH, or N (CH3). The compounds are antagonists of the MCP-1 function, and are useful in the prevention and treatment of chronic or acute autoimmune and inflammatory diseases such as atherosclerosis, Crohn's disease, diabetic nephropathy, inflammatory bowel disease, multiple sclerosis, nephritis, pancreatitis, fibrosis pulmonary, psoriasis, restenosis, rheumatoid arthritis and transplant rejection; and of allergic hypersensitivity diseases such as allergic rhinitis and asthma. In addition, pharmaceutical compositions comprising the compounds, the use of these compounds in the preparation of medicaments, and processes for the preparation of the compounds are described.

ARP040102812A 2002-01-29 2004-08-06 ACILUREA COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS, USE OF THE COMPOUNDS IN THE PREPARATION OF MEDICINES, AND PROCESSES FOR THE PREPARATION OF THE COMPOUNDS AR045341A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/060,967 US6670364B2 (en) 2001-01-31 2002-01-29 Antagonists of MCP-1 function and methods of use thereof
US10/637,746 US6962926B2 (en) 2001-01-31 2003-08-08 Antagonist of MCP-1 function, and compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
AR045341A1 true AR045341A1 (en) 2005-10-26

Family

ID=43014121

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102812A AR045341A1 (en) 2002-01-29 2004-08-06 ACILUREA COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS, USE OF THE COMPOUNDS IN THE PREPARATION OF MEDICINES, AND PROCESSES FOR THE PREPARATION OF THE COMPOUNDS

Country Status (1)

Country Link
AR (1) AR045341A1 (en)

Similar Documents

Publication Publication Date Title
AR023823A1 (en) COMPOUNDS DERIVED FROM PIPERAZINE USEFUL AS CCTA5 ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
Lima et al. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues
UY29451A1 (en) NEW DERIVATIVES OF (1,3) TIAZOLO (4,5-D) PIRIMIDIN-2- (3H) -ONA 5,7-DISUSTITUTED
UY29454A1 (en) NOVELTY DERIVATIVES OF 7-AMINO- (1,3) TIAZOL (4,5-D) PYRIMIDINE 5-SUBSTITUTES
UY28059A1 (en) NEW DERIVATIVES OF DIHYDROPIRIMIDO (4,5-D) PYRIMIDONE REPLACED BY AMINO. MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS.
ZA200702688B (en) Substituted 2H-1,3-benzoxazin-4-(3H)-ones
RU2008110941A (en) P38 MAR KINASE INHIBITORS AND WAYS OF THEIR APPLICATION
HRP20050309A2 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
MXPA05011710A (en) Fused pyrimidine derivatives with crf activity.
MY152888A (en) Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists.
HRP20050383A2 (en) Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
BRPI0509720A (en) substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
MX2010005753A (en) Isoxazolo-pyrazine derivatives.
CY1105198T1 (en) PIPEIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)
DE60317889D1 (en) ANTIVIRAL BICYCLO 4.4.0 DERIVATIVES
CL2003002565A1 (en) COMPOUNDS DERIVED FROM 3H-QUINAZOLIN-4-ONA, ITS PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE IN THE TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MAO-B INHIBITORS, SUCH AS THE DISEASE OF ALZHEIMER AND DEMENCIER
Mahesh et al. Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression
US20050187228A1 (en) Derivatives of purine, their preparation process and pharmaceutical compositions containing them
BR0312780A (en) Substituted thiophene carboxamide compounds for the treatment of inflammation
HUP0401093A2 (en) Piperazine oxime derivatives having nk-1 receptor antagonistic activity, pharmaceutical compositions containing them and process for preparation the compounds
AR045341A1 (en) ACILUREA COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS, USE OF THE COMPOUNDS IN THE PREPARATION OF MEDICINES, AND PROCESSES FOR THE PREPARATION OF THE COMPOUNDS
WO2008039139A8 (en) Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy
UY30612A1 (en) DERIVATIVES 5,7 DISPOSED OF THE [1,3] TIAZOLO [4,5, D] PIRIMIDIN-2 (3H) -ONA, PREPARATION PROCESS AND APPLICATIONS
ES2083708T3 (en) NEW PIPERAZINILALCOIL-3 DIHYDRO-2,3,4H-BENZOXAZINE-1,3 ONAS-4 SUBSTITUTED, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
JP2004501921A (en) 5-aminoalkylpyrazolo [4,3-d] pyrimidine

Legal Events

Date Code Title Description
FB Suspension of granting procedure